NCT03676725View on ClinicalTrials.gov

Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
ADHDPMS
Interventions
DRUG

Lidocaine gel

Lidocaine gel (0.75 g premeasured dose of Septodont 5% oral gel NDC 0362-0221-10)

Trial Locations (2)

10461

Jacobi Medical Center, The Bronx

02131

Boston Clinical Trials, Boston

Sponsors
All Listed Sponsors
collaborator

Jacobi Medical Center

OTHER

collaborator

Boston Clinical Trials

OTHER

lead

PhenoSolve, LLC

INDUSTRY

NCT03676725 - Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD | Biotech Hunter | Biotech Hunter